Evidence map›Paper›PMID 29595433›Full record

ArticleHealthcare policy = Politiques de sante2018

Research on Human Embryos and Reproductive Materials: Revisiting Canadian Law and Policy.

Ubaka Ogbogu, Amy Zarzeczny, Jay Baltz, Patrick Bedford, Jenny Du, Insoo Hyun, Yasmeen Jaafar, Andrea Jurisicova, Erika Kleiderman, Yonida Koukio and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare policy = Politiques de sante, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Canada'sFrontiers in medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ubaka OgboguAssistant Professor, Faculties of Law and Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB.
Amy ZarzecznyAssociate Professor, Johnson-Shoyama Graduate School of Public Policy, University of Regina, Regina, SK.
Jay BaltzSenior Scientist and Professor, Ottawa Hospital Research Institute, Faculty of Medicine, University of Ottawa, Ottawa, ON.
Patrick BedfordManager of Clinical Translation and Regulatory Affairs, Centre for Commercialization of Regenerative Medicine (CCRM), Toronto, ON.
Jenny DuResearch Trainee, Faculty of Law, University of Alberta, Edmonton, AB.
Insoo HyunAssociate Professor, Department of Bioethics, Case Western Reserve University, Cleveland, OH.
Yasmeen JaafarResearch Trainee, Faculty of Law, University of Alberta, Edmonton, AB.
Andrea JurisicovaAssociate Professor, Department of Obstetrics and Gynecology, University of Toronto, Investigator, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON.
Erika KleidermanAcademic Associate, Centre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University, Montreal, QC.
Yonida KoukioLLM Candidate, Osgoode Hall Law School, Toronto, ON.
Bartha Maria KnoppersProfessor and Director, Centre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University, Montreal, QC.
Arthur LeaderProfessor of Reproductive Medicine, Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON.
Zubin MasterAssociate Consultant II, Biomedical Ethics Research Program, Mayo Clinic, Rochester, MN.
Minh Thu NguyenAcademic Associate, Centre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University, Montreal, QC.
Forough NoohiPhD Candidate, Centre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University, Montreal, QC.
Vardit RavitskyAssociate Professor, Bioethics Programs, School of Public Health, University of Montreal, Montreal, QC.
Maeghan ToewsLecturer, Faculty of Law, University of Adelaide, Adelaide, AU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research involving human embryos and reproductive materials, including certain forms of stem cell and genetic research, is a fast-moving area of science with demonstrated clinical relevance. Canada's current governance framework for this field of research urgently requires review and reconsideration in view of emerging applications. Based on a workshop involving ethics, legal, policy, scientific and clinical experts, we present a series of recommendations with the goal of informing and supporting health policy and decision-making regarding the governance of the field. With a pragmatic and principled governance approach, Canada can continue its global leadership in this field, as well as advance the long-term health and well-being of Canadians.

Indexed as

Health PolicyCanadaEmbryo ResearchGenetic ResearchHumansStem Cell Research

Identifiers

PMID29595433
PMCPMC5863866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.